NCT03146065View on ClinicalTrials.gov

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512

PHASE1CompletedINTERVENTIONAL

Enrollment

79

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

May 3, 2018

Study Completion Date

May 3, 2018

Conditions

Healthy

Interventions

BIOLOGICAL

PF-06730512

Comparison of different dosages of PF-06730512 to Placebo

DRUG

Placebo

Comparison of Placebo to different doses of PF-06730512

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY